A randomized controlled trial on the effect of hydroxychloroquine in mild Graves’ orbitopathy (GO-HCQ): study protocol
Abstract Background Graves’ orbitopathy (GO) is a prevalent manifestation of Graves’ disease (GD), characterized by proptosis, eyelid retraction, soft tissue swelling, diplopia, and potential visual acuity impairment. Furthermore, even mild GO can significantly impact mental health and overall quali...
Saved in:
| Main Authors: | Chia-Hung Lin, Yi-Hsuan Wei, Jin-Ying Lu, Hung-Yuan Li, Chung-Wei Lee, Chung-Yi Yang, Chin-Hao Chang, Wan-Chen Wu, Chih-Yuan Wang, Shyang-Rong Shih |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Trials |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13063-025-09002-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of hormonal imbalance in the development of autoimmune dacryoadenitis in endocrine orbitopathy
by: V. G. Likhvantseva, et al.
Published: (2014-07-01) -
MMP14 as a central mediator of TGF-β1−induced extracellular matrix remodeling in graves’ orbitopathy
by: Xing Wang, et al.
Published: (2025-07-01) -
An Update on Medical Management of Thyroid Eye Disease with Insights on Teprotumumab
by: Smriti Dabas, et al.
Published: (2023-07-01) -
Indicators of oxidative stress and tissue hypoxia in various phases of Graves’ orbitopathy activity
by: E. S. Taskina, et al.
Published: (2024-11-01) -
Long-term outcomes of graves disease in children treated with anti-thyroid drugs
by: Ya-Ting Chiang, et al.
Published: (2020-06-01)